Neuromuscular blockade in the ICU: if you can't measure it, you can't manage it.
2022
C R Bailey
Department of Anaesthetics, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
UI
MeSH Term
Description
Entries
D007362
Intensive Care Units
Hospital units providing continuous surveillance and care to acutely ill patients.
ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D006801
Humans
Members of the species Homo sapiens.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000777
Anesthetics
Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site.
The intentional interruption of transmission at the NEUROMUSCULAR JUNCTION by external agents, usually neuromuscular blocking agents. It is distinguished from NERVE BLOCK in which nerve conduction (NEURAL CONDUCTION) is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce MUSCLE RELAXATION as an adjunct to anesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anesthesia but is grouped here with anesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here.